Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women

American Journal of Geriatric Psychiatry

Volumn 10, Issue 3, 2002, Pages 311-320

  Breuer, Brenda ^a,b   Martucci, Charles ^e   Wallenstein, Sylvan ^d   Likourezos, Antonios ^a,b   Libow, Leslie S ^a,b   Peterson, Ann ^c   Zumoff, Barnett ^f  

^a Jewish Home and Hospital   (United States)

^b Box 1070   (United States)

^c Departments of Psychiatry and Behavioral Sciences   (United States)

^d The Department of Biomathematics   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRONE; PRASTERONE; SEX HORMONE; TESTOSTERONE;

AGED; ARTICLE; COGNITION; DEPRESSION; FEMALE; GERIATRIC PATIENT; HORMONE DETERMINATION; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PREVALENCE; STRESS;

EID: 0036093982     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200205000-00011     Document Type: Article

References (74)

1. In-vivo effects by estrone sulfate on the central nervous system: Senile dementia (Alzheimer's type)
2. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects
3. Hormones, mood, and cognitive functioning in post-menopausal women
4. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study
5. Dehydroepiandrosterone sulfate in a long-term care aged population
6. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study
7. High, usual, and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on Successful Aging
8. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: Seven case reports
9. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
10. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease
11. Estrogen deficiency and risk of Alzheimer's disease in women
12. Cognitive function and endogenous sex hormones in older women
13. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women
14. Estrogen replacement therapy and memory in older women
15. Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect?
16. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study
17. Estrogen replacement therapy and cognitive decline in older community women
18. Determinants of functional status in healthy Italian nonagenarians and centenarians: A comprehensive functional assessment by the instruments of geriatric practice
19. Estrogen improves psychological function in asymptomatic postmenopausal women
20. Comparative psychologic effects of estrogen administration on institutional and noninstitutional elderly women
21. Sex hormones and cognitive functioning in men
22. The relationship between testosterone levels and cognitive ability patterns
23. Estrogen use and verbal memory in healthy postmenopausal women
24. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia
25. Estrogen replacement therapy and cognitive function in older women
26. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
27. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women
28. Cognitive and noncognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone
29. Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population
30. Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population
31. Estrogen replacement therapy for treatment of mild-to-moderate Alzheimer's disease: A randomized controlled trial: Alzheimer's Disease Cooperative Study
32. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
33. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature
34. Estrogen use and depressive symptoms in postmenopausal women
35. Observations in a preliminary open trial of estradiol therapy for senile dementia, Alzheimer's type
36. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study
37. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women
38. Physical and psychosocial correlates of hormone replacement therapy with chronically stressed postmenopausal women
39. 2) levels in Alzheimer's disease (AD) patients
40. Hormone therapy and affect
41. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebocontrolled trial
42. Oestrogen therapy and the menopausal syndrome
43. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study
44. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men
45. The effect of exogenous oestrogens on depression in menopausal women
46. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women
47. Reliability and interrelations among serum sex hormones in postmenopausal women
48. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids
49. Dehydroepiandrosterone sulphate in rat brain: Incorporation from blood and metabolism in vivo
50. Assay reproducibility of hormone measurements in postmenopausal women
51. Cornell Scale for Depression in Dementia
52. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
53. Cognitive Performance Scale
54. The test for severe impairment: An instrument for the assessment of patients with severe cognitive dysfunction
55. Clock drawing in Alzheimer's disease: A novel measure of dementia severity
56. Rethinking estrogen and the brain
57. Problems of differential diagnosis between depressive pseudodementia and Alzheimer's disease
58. Endogenous sex hormones and cognitive function in older men
59. Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration
60. 2 protein in sera and tumors of breast cancer patients
61. Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: A case-control study in Rochester, Minnesota, 1980 through 1984
62. Aspirin use and cognitive function in the elderly
63. Temporal order of cognitive and functional loss in a nursing home population
64. Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man
65. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for reduced 17,20-desmolase enzymatic activity
66. Androgen and estrogen dynamics: Relationships with age, weight, and menopausal status
67. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome
68. Increased cortisol levels and impaired cognition in human aging: Implication for depression and dementia in later life
69. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly
70. Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study
71. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man